{"organizations": [], "uuid": "5d55a3a29a343b489e4ff8a0e374bff3ab5834c9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180212.html", "section_title": "Archive News &amp; Video for Monday, 12 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-sanofi-pasteur-strucks-licence-agr/brief-sanofi-pasteur-strucks-licence-agreement-with-sk-chemicals-idUSFWN1Q20OJ", "country": "US", "domain_rank": 408, "title": "BRIEF-Sanofi Pasteur strucks licence agreement with SK Chemicals", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-02-12T19:41:00.000+02:00", "replies_count": 0, "uuid": "5d55a3a29a343b489e4ff8a0e374bff3ab5834c9"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-sanofi-pasteur-strucks-licence-agr/brief-sanofi-pasteur-strucks-licence-agreement-with-sk-chemicals-idUSFWN1Q20OJ", "ord_in_thread": 0, "title": "BRIEF-Sanofi Pasteur strucks licence agreement with SK Chemicals", "locations": [], "entities": {"persons": [{"name": "sanofi pasteur", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "sk chemicals", "sentiment": "negative"}, {"name": "sanofi pasteur", "sentiment": "none"}, {"name": "sanofi", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 12 (Reuters) - Sanofi:\n* SK Chemicals announces license agreement with Sanofi Pasteur in cell culture technology for potential use in Sanofiâ€™s strategic broadly protective influenza vaccine development program\n* agreement between SK Chemicals and Sanofi Pasteur is eligible for payment of up to $155 million when achieving all milestones Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-12T19:41:00.000+02:00", "crawled": "2018-02-13T15:47:53.005+02:00", "highlightTitle": ""}